Govt to treat Bharat Biotech's Covaxin same as AstraZeneca's Premium Administering Bharat Biotech's COVAXIN, has worried some health experts who consider it rushed, as the vaccine has only limited, 'clinical-trial mode' approval (Photo: PTI) Krishna N. Das, , Reuters 'No vaccine is a backup to the other - both vaccines are equally important, both vaccines are hugely immunogenic,' Vinod K. Paul, who heads a government panel on vaccine strategy, said. 'They excite immunity against the virus', he added Share Via Read Full Story NEW DELHI : India will treat a domestic COVID-19 vaccine "equally"...